Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

ISSN: 2073-4409

DOI: 10.3390/cells9061525

LINK: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087098529&origin=inward